About

European citizens are seeking Complementary and Alternative Medicine, also when offered outside their national health care system. Regulation is an important management tool in risk governance of health care services.  The objective of giving an overview of the regulation of Complementary and Alternative Medicine (CAM) in the European/EU countries is primarily to enable European citizens to make informed and safe choices when they seek CAM treatments.

Regulations of importance can cover requirements with regard to the education of providers, standardized and safe treatments, registry of professionals, as well as supervision and professional title protection.

General CAM legislation in 39 European/EU countries

Click on image to enlarge

CAM regulation differs highly from one country to the other. ”Complementary and Alternative Medicine (CAM) is, in Europe, regulated either as conventional, complementary or alternative medicine, or not regulated at all. CAM regulation is, however, different in each of the 39 European countries included in the CAMbrella WP2 survey. Consequently an essential question is; What are the patient safety implications of the European disharmonious landscape of health regulation?” Wiesener, 2013 (318).

 

This website provides answers to the following questions:

  • Which therapies are considered and regulated as CAM in a given European/EU country?
  • How is a specific CAM treatment regulated in an European/EU country?
  • Whether CAM treatment is reimbursed or not?
  • Under which legal conditions do CAM providers practice in a given European/EU country?
  • What are the national educational and training requirements for a CAM practitioner in a given European/EU country?
  • Which of the given European/EU country’s acts and regulations apply to the various CAM providers?
  • Which health conditions are illegal for CAM providers to treat?

The website is owned and operated by NAFKAM – Norway’s National Research Center in Complementary and Alternative Medicine.

NAFKAMs mission is to generate and disseminate unbiased, research-based knowledge about CAM in order to help people make well-informed choices for their own health. NAFKAM was responsible for work package (WP) 2 in the EU-funded CAMbrella project, which summarized the legal and regulatory status, governmental supervision and the reimbursement status of 12 selected CAM practices in 39 European countries.

The CAM Regulation database is a hard copy of the CAMbrella findings, and will be updated with new regulation found after the CAMbrella deliveries. (See News.)

Acknowledgement
Authors of the three reports included in the CAMbrella WP2 project are:
(Lead author in bold print)

  1. Deliverable 9 – Report No. 1 – CAM regulations in the European countries
    Authors: S Wiesener,T Falkenberg, G Hegyi, J Hök, P Roberti di Sarsina, V Fønnebø
  2. Deliverable 9 – Report No. 2 – Herbal and homeopathic medicinal products
    Authors: V Fønnebø, T Kristensen Tunby, T Falkenberg, G Hegyi, J Hök, P Roberti di Sarsina, S Wiesener
  3. Deliverable 9 – Report No. 3 – CAM regulations in EU/EFTA/EEA
    Authors: S Wiesener,T Falkenberg, G Hegyi, J Hök, P Roberti di Sarsina, V Fønnebø

Download the reports here.